Information, deadlines and resource documents for U.S. tariff actions and the responses by the rest of the world.
Internationally recognized trade compliance training.
Subscribe to daily updates
The Drug Enforcement Administration has announced its intent to issue an order temporarily including the synthetic opioid N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl or acryloylfentanyl) into schedule I of the Controlled Substances Act. Available data and information indicate that this substance has a high potential for abuse, no currently accepted medical use in treatment in the U.S., and a lack of accepted safety for use under medical supervision.
The temporary scheduling order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances under the CSA on the manufacture, distribution, reverse distribution, possession, importation, exportation, research and conduct of instructional activities, and chemical analysis of this substance. It will be effective on the date it is published in the Federal Register, which will take place as soon as possible after July 3, and will remain in effect for two years, with a possible extension of one year.